4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-13-004559
CIK 0000875622operating
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 9:58 PM ET
Size
9.4 KB
Accession
0001062993-13-004559
Insider Transaction Report
Form 4
Morgan Henry
Director
Transactions
- Sale
Common Stock, $0.001 par value
2013-09-04$18.55/sh−5,000$92,750→ 25,043 total - Sale
Common Stock, $0.001 par value
2013-09-04$18.50/sh−5,000$92,500→ 30,043 total - Sale
Common Stock, $0.001 par value
2013-09-04$18.60/sh−2,402$44,677→ 22,641 total - Sale
Common Stock, $0.001 par value
2013-09-05$18.35/sh−5,448$99,971→ 17,193 total
Footnotes (4)
- [F1]Selling price of $18.50 is reflective of the weighted average sale price of all transactions reported on this line.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $18.55 to $18.56. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Selling price of $18.60 is reflective of the weighted average sale price of all transactions reported on this line.
- [F4]Selling price of $18.35 is reflective of the weighted average sale price of all transactions reported on this line.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 9:58 PM ET
- Size
- 9.4 KB